Xavier Cruz Correia

4PUBLICATIONS
15CO-AUTHORS
Pharmaceutical delivery technologiesBiologically active moleculesNeurology and neuromuscular diseasesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2026
Dual-Acting Vitamin B3-Melanostatin Neuropeptide Hybrids as Potent Modulators of the Dopamine D2 Receptors with Neuroprotective Activity.

|Aug 20, 2025
Proline Homologation in Melanostatin Neuropeptide: Discovery of Potent Modulators of the Dopamine D2 Receptors.

Ivo E Sampaio-Dias, Hugo F Costa-Almeida, Xavier C Correia

|Sep 18, 2024
Discovery of hybrid Glypromate conjugates with neuroprotective activity against paraquat-induced toxicity.

Sara C Silva-Reis, Vera M Costa, Daniela Correia da Silva

|Dec 20, 2023
Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D2 Receptors.

Sara C Silva-Reis, Xavier C Correia, Hugo F Costa-Almeida

Pageof 1

Frequent Collaborators

4 joint publications

Sara C Silva-Reis

4 joint publications

Ivo E Sampaio-Dias

3 joint publications

Hugo F Costa-Almeida

3 joint publications

Vera M Costa